CMP Pharma, Inc Announces that Atorvaliq®, the First and Only FDA-approved Liquid Suspension of Atorvastatin
23 Jun 2023 //
PR NEWSWIRE
CMP PharmaAnnounces that Liqrev®, the First and Only Ready-made FDA-approved
21 Jun 2023 //
PR NEWSWIRE
CMP Pharma`s Potassium Phosphates Injection Receives FDA Shelf Life Extension
31 Mar 2023 //
PR NEWSWIRE
CMP Pharma, Inc Announces that Tadliq is Now Available
24 Oct 2022 //
PRNEWSWIRE
CMP Pharma Announces that Norliqva is Now Available
01 Jun 2022 //
PRNEWSWIRE
CMP Pharma, Inc. Announces Unit Dose Packaging for CaroSpir®
18 Oct 2021 //
PRNEWSWIRE